National Bank of Canada’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-184
Closed -$513 3142
2025
Q4
$513 Hold
184
﹤0.01% 2695
2025
Q3
$881 Buy
184
+83
+82% +$528 ﹤0.01% 2656
2025
Q2
$917 Buy
+101
New +$744 ﹤0.01% 2713
2024
Q4
Sell
-2
Closed -$31 3135
2024
Q3
$31 Sell
2
-48
-96% -$727 ﹤0.01% 2617
2024
Q2
$648 Hold
50
﹤0.01% 2545
2024
Q1
$931 Buy
+50
New +$1.11K ﹤0.01% 2550
2023
Q4
Sell
-50
Closed -$826 2841
2023
Q3
$826 Hold
50
﹤0.01% 2611
2023
Q2
$950 Buy
50
+25
+100% +$446 ﹤0.01% 2561
2023
Q1
$364 Hold
25
﹤0.01% 2608
2022
Q4
$488 Buy
+25
New +$488 ﹤0.01% 2649
2022
Q3
Sell
-583
Closed -$18K 2827
2022
Q2
$18K Hold
583
﹤0.01% 2109
2022
Q1
$26K Buy
583
+366
+169% +$15.7K ﹤0.01% 2095
2021
Q4
$9K Buy
+217
New +$8.51K ﹤0.01% 2399

Other funds holding ACH

National Bank of Canada's ACH Position: Q1 2026 in Review

National Bank of Canada sold out of Accendra Health (ACH) in Q1 2026, closing a stake of 184 shares — an estimated $513 sold.

National Bank of Canada first reported a position in ACH in Q4 2021 and held it in 13 quarters. The position peaked at $26K in Q1 2022. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

  • National Bank of Canada reported no remaining Accendra Health position as of Q1 2026 after selling out during the quarter.
  • National Bank of Canada sold 184 Accendra Health shares in Q1 2026, an estimated $513.
  • National Bank of Canada first reported a position in Accendra Health in Q4 2021 and held it in 13 quarters.
  • National Bank of Canada's Accendra Health position peaked at $26K in Q1 2022.
  • 142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.